Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,070 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 626-650 of 796 matching filings.

Per page
25
Current page
26
D File 021-203611

D filing

Filing date
26 Sep 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS PHARMACEUTICALS, INC.

Filing date
26 Sep 2013
Reporting date
20 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Sep 2013
Reporting date
20 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS PHARMACEUTICALS, INC. 8-K SEPTEMBER 10, 2013

Filing date
13 Sep 2013
Reporting date
10 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Aug 2013
Reporting date
19 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Aug 2013
Reporting date
19 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Aug 2013
Reporting date
19 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Aug 2013
Reporting date
19 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Aug 2013
Reporting date
19 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-187803

424B3

Filing date
08 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

8-K

Filing date
26 Jul 2013
Reporting date
22 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-182476

PROSPECTUS SUPPLEMENT

Filing date
26 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS PHARMACEUTICALS, INC. 8-K JUNE 27, 2013

Filing date
02 Jul 2013
Reporting date
27 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 May 2013
Reporting date
29 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-187803

PROSPECTUS SUPPLEMENT 424B3

Filing date
10 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-09410

DEF 14A

Filing date
30 Apr 2013
Reporting date
27 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-09410

PRE 14A

Filing date
19 Apr 2013
Reporting date
27 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS PHARMACEUTICALS, INC. 8-K APRIL 12, 2013

Filing date
18 Apr 2013
Reporting date
12 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-187803

424B3

Filing date
16 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-187803

EFFECT filing

Filing date
15 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-175578

EFFECT filing

Filing date
09 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-167906

EFFECT filing

Filing date
09 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .